Zdrowie i gospodarka · 18/09/2025
FDA Reclassifies Hepatitis B Virus Assay Devices
The FDA is reclassifying certain hepatitis B virus assay devices, including antigen and antibody tests, from Class III to Class II, requiring premarket notification and special controls to ensure safety and effectiveness.
Source: Federal Register — Food and Drug AdministrationOpen original release →